AdvertisementFDA advisers reject MDMA therapy for PTSD, amid concerns over researchPlay03:30Download AudioUpdated June 04, 2024Will StonefacebookEmailA dose of MDMA. The drug has been studied as a treatment for PTSD and FDA is now considering whether to approve it. (Getty Images)This article was originally published on June 04, 2024.